Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReBIC-1: Furosemide Withdrawal in Stable Chronic Heart Failure
NCT02689180Phase 3Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of furosemide in heart failure (HF), sponsored by Hospital de Clínicas de Porto Alegre. Status: unknown.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02689180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689180.